COMPARISON OF PACE CLINICAL TRIAL VS REAL-WORLD PONATINIB PRESCRIBING AND DURATION OF THERAPY IN CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS

EHA Library, Michael Mauro, 132657

PATIENT-REPORTED OUTCOMES FROM AN OPEN-LABEL SAFETY AND EFFICACY STUDY OF BOSUTINIB IN PHILADELPHIA CHROMOSOME–POSITIVE CHRONIC MYELOID LEUKEMIA RESISTANT OR INTOLERANT TO PRIOR THERAPY

EHA Library, Jorge Cortes, 132658

PRELIMINARY FINDINGS FROM A CHART REVIEW OF LOWER DOSING OF PONATINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS

EHA Library, Michael Mauro, 132659

IMPACT OF IMATINIB PHARMACOKINETICS ON HEALTH RELATED QUALITY OF LIFE AND ADVERSE EVENTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Jinyi Cao, 132660

CMREGISTRY: AN OBSERVATIONAL, MULTI CENTER, PROSPECTIVE FOLLOW-UP REGISTRY OF PATIENTS WITH CHRONIC PHASE CML WITH A HIGH PROBABILITY OF OBTAINING A STABLE DEEP MOLECULAR RESPONSE >CMR4 (IS).

EHA Library, Eduardo Olavarria, 132661

BCR-ABL1 MONITORING ON THE IS USING AN ANALYTICALY AND CLINICALLY VALIDATED MULTIPLEX ASSAY DIRECTLY ALIGNED TO THE WHO PRIMARY STANDARDS

EHA Library, Justin Brown, 132662

RESULTS OF OBSERVATION WITHOUT TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE WHO STOPPED THERAPY DUE TO PREGNANCY, ADVERSE EVENTS OR BY OWN CONSIDERATION

EHA Library, Ekaterina Chelysheva, 132663

CONCURRENT OPTIMAL MOLECULAR AND CYTOGENETIC RESPONSES AT BOTH 3 AND 6 MONTHS PREDICT A HIGHER PROBABILITY OF MR4.5 ACHIEVEMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB

EHA Library, Ya-Zhen Qin, 132664

THE JAK1/2 INHIBITOR RUXOLITINIB MODULATES ANTIGEN PRESENTING FUNCTIONS OF ACTIVATED PRIMARY B CELLS ON A METABOLIC LEVEL

EHA Library, Sebastian Theurich, 132665

INTRA-BONE DONOR LYMPHOCYTE INFUSION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES RELAPSING POST ALLOHSCT

EHA Library, Andrzej Lange, 132666

INTERLEUKIN-2-PRIMED NAÏVE CD8 T CELLS AS A POTENTIAL REMEDY FOR OVERCOMING TUMOR-DERIVED IMMUNOSUPPRESSION IN TUMOR MICROENVIRONMENT

EHA Library, Deok-Hwan Yang, 132667

SYNERGISTIC KILLING EFFECT OF A NOVEL TRIPLE-REGULATED ONCOLYTIC ADENOVIRUS CARRYING PROGRAMMED CELL DEATH 5 GENE AND DAUNORUBICIN ON HUMAN LEUKEMIC CELLS

EHA Library, Guo-Rui Ruan, 132668

TRIPLE-REGULATED ONCOLYTIC ADENOVIRUS-MEDIATED VSTM1 OVEREXPRESSION EXHIBITS POTENT ANTITUMOR ACTIVITY ON COMMON HUMAN LEUKEMIC CELL LINES

EHA Library, Guo-Rui Ruan, 132669

COMBINED ISOLATION OF MULTI ANTIGEN SPECIFIC T CELL PRODUCTS CONTAINING NAÏVE AND/OR MEMORY VIRUS-SPECIFIC T CELLS AND T CELLS SPECIFIC FOR TUMOR ASSOCIATED AND MINOR HISTOCOMPATIBILITY ANTIGENS

EHA Library, Inge Jedema, 132670

THE IGE REPERTOIRE IN HEALTHY, NON-ALLERGIC INDIVIDUALS: IMPLICATIONS FOR EFFICIENT ALLERGEN DESENSITATION IMMUNOTHERAPY

EHA Library, Marvyn Koning, 132671

THE EFFECTS OF VARIOUS BLOOD PROTEINS ON THE ZETA POTENTIAL OF POLYMER NANOPARTICLES AND PROTEIN CORONA FORMATION: AN ANALYSIS BY TUNABLE RESISTIVE PULSE SENSING

EHA Library, M Sivakumaran, 132672

EXPANDING THE KNOWLEDGE OF BLOOD TRANSCRIPTOME: CIRCULAR RNAS IN HEMATOPOIESIS

EHA Library, Annagiulia Bonizzato, 132673

THE APC/C COACTIVATOR CDH1 CONTROLS MAINTENANCE OF THE HEMATOPOIETIC STEM CELL POOL IN VIVO

EHA Library, Stefanie Kreutmair, 132674

THE TRANSCRIPTION FACTOR C/EBPG IS RESPONSIBLE FOR RAPID PRODUCTION OF NEUTROPHILS DURING EMERGENCY GRANULOPOIESIS

EHA Library, Miroslava Kardosova, 132675

TELOMERASE MRNA IN T CELL LEUKEMIA CELL LINE (JURKAT) DERIVED EXOSOMES TRANSFORMS NONMALIGNANT FIBROBLASTS INTO TELOMERASE POSITIVE CELLS

EHA Library, Meir Lahav, 132677

PERIPHERAL BLOOD LEUKOCYTE TELOMERE LENGTH AND RISK OF INFECTIOUS DISEASE: A PROSPECTIVE STUDY OF 75,919 INDIVIDUALS FROM THE GENERAL POPULATION

EHA Library, Jens Helby Petersen, 132678

ABNORMAL EXPRESSION OF PYRUVATE KINASE M2 IN MYELOID DENDRITIC CELLS OF THE PATIENTS WITH SEVERE APLASTIC ANEMIA

EHA Library, Shao Zonghong, 132679

ANALYSIS OF T CELL SUBSETS IN G-CSF PRIMED BONE MARROW FOR ALLOGENEIC STEM CELL TRANSPLANTATION AND ITS ASSOCIATION WITH CHRONIC GVHD INCIDENCE

EHA Library, Eucario Leon Rodriguez, 132680

DYSFUNCTION OF BONE MARROW ENDOTHELIAL PROGENITOR CELLS FROM SUBJECTS WITH POOR GRAFT FUNCTION FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN BE IMPROVED BY ATORVASTATIN

EHA Library, Minmin Shi, 132681

MULTIPOTENT PROGENITOR CELLS AND ACQUIREMENT OF HEMATOPOIETIC CAPACITY IN THE BONE MARROW OF XENOPUS LAEVIS

EHA Library, Yuta Tanizaki, 132682

BONE MARROW STROMAL CELLS FUNCTIONAL CHARACTERISTICS STUDY IN RECIPIENTS BEFORE ALLO-BMT.

EHA Library, Ildar Barkhatov, 132683

G-CSF TREATMENT IN VIVO INDUCES BONE MARROW RELEASE OF PD-L1 POSITIVE MYELOID DERIVED SUPPRESSIVE CELLS.

EHA Library, Emilie Lereclus, 132684

ALTERATIONS OF BONE MARROW MICROENVIRONMENT IN PATIENTS WITH HEMATOLOGICAL DISORDERS AT THE DIAGNOSIS AND DURING THE TREATMENT

EHA Library, Tamara Sorokina, 132685

COMPARISON OF MOLECULAR AND FUNCTIONAL PROFILES OF WHARTON’S JELLY AND BONE MARROW MESENCHYMAL STEM CELLS

EHA Library, Charalampos Pontikoglou, 132686

IMPACT OF LEUKEMIA STEM CELLS PHENOTYPE EXPRESSION ON RESPONSE TO INDUCTION THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, faez almohsen, 132687

VASCULAR ENDOTHELIAL CELL-RELATING MOLECULES EXPRESSED IN AN ADULT HUMAN DERMAL FIBROBLAST WHEN CULTURED WITH INTERLEUKIN-1-BETA

EHA Library, Ritsu Sumiyoshi, 132688

THYROID DISEASES IN LYMPHOMA SURVIVORS

EHA Library, Maria Pina Simula, 132689

PROGNOSTIC RELEVANCE OF SERUM FERRITIN LEVELS IN HODGKIN LYMPHOMA (HL) UNDER TREATMENT WITH ABVD OR EQUIVALENT REGIMENS WITH OR WITHOUT RADIOTHERAPY (RT)

EHA Library, Theodoros Vassilakopoulos, 132691

INFRADIAPHRAGMATIC HODGKIN LYMPHOMA: A LARGE SERIE OF PATIENTS AT THE ERA OF TEP-CT. A PARTICULAR SUBSET OF HL?

EHA Library, Cédric Rossi, 132692

RESULTS AND OUTCOME WITH ABVD-PLATINE PROTOCOL IN HODGKIN LYMPHOMA WITH BULKY MEDIASTINAL INVOLVEMENT

EHA Library, R-M Hamladji, 132693

ADDITION OF ABSOLUTE LYMPHOCYTES/MONOCYTES RATIO IMPROVES THE STANDARD PROGNOSTIC SCORES FOR ADVANCED AND LOCALIZED HODGKIN LYMPHOMA PATIENTS TREATED WITH ABVD +/- RADIOTHERAPY.

EHA Library, Inés Herráez Balanzat, 132694

BRENTUXIMAB VEDOTIN-BENDAMUSTINE COMBINATION FOR HODGKIN LYMPHOMA: EXPERIMENT WITH 8 PATIENTS.

EHA Library, Candice Carola, 132695

HODGKIN LYMPHOMA: A RETROSPECTIVE ANALYSIS OF SURVIVAL AND TREATMENT RELATED TOXICITIES OF A COHORT OF PATIENTS DIAGNOSED BETWEEN 2005-2015

EHA Library, Gil Brás, 132696

HIGH THROUGHPUT TCR SEQUENCING PROVIDES ADDED VALUE IN THE DIAGNOSIS OF CUTANEOUS T-CELL LYMPHOMA

EHA Library, Ilan Kirsch, 132697

SENSITIVITY OF ULTRASOUND-GUIDED 16 G CORE-NEEDLE CUTTING BIOPSY AND EXCISIONAL BIOPSY FOR THE CHARACTERIZATION OF LYMPHADENOPATHIES IN PATIENTS WITH SUSPECTED LYMPHOMA: A RANDOMIZED SUPERIORITY TRIAL

EHA Library, Novella Pugliese, 132698

MCL-002: UPDATED EFFICACY AND SAFETY RESULTS FOR LENALIDOMIDE VS. INVESTIGATOR’S CHOICE MONOTHERAPY IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA

EHA Library, Luca Arcaini, 132699

POSITIVE BENEFITS OF CHANGING FROM INTRAVENOUS RITUXIMAB ADMINISTRATION TO SUBCUTANEOUS ADMINISTRATION: A SINGLE UK CENTRE EXPERIENCE

EHA Library, Sarah Irwin, 132700

IMPACT OF STABLE DISEASE OR BETTER RESPONSES TO LENALIDOMIDE ON SURVIVAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: MCL-001 (EMERGE) AND MCL-002 (SPRINT) STUDIES

EHA Library, Andre Goy, 132701

TREATMENT AND PROGNOSIS OF STAGE I FOLLICULAR LYMPHOMA IN THE MODERN ERA - DOES PET-CT MATTER?

EHA Library, Ohad Bentur, 132702

PATTERNS OF HEMOGRAM CHANGES IN PATIENTS WITH RELAPSED/REFRACTORY INHL AND CLL TREATED WITH IDELALISIB

EHA Library, Stephan Stilgenbauer, 132703

A PHASE II STUDY OF THE COMBINATION OF OFATUMUMAB WITH FLUDARABINE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY WALDENSTRÖM’S MACROGLOBULINEMIA

EHA Library, Efstathios Kastritis, 132704

MOLECULAR ACTIVITY IN FOLLICULAR LYMPHOMA MONITORED BY BCL2/IGH IN THE PERIPHERAL BLOOD. THE OLD STORY IN A NEW LIGHT?

EHA Library, Eva Miculkova, 132705

THE IMPACT OF HISTOLOGIC GRADING ON THE OUTCOME OF FOLLICULAR LYMPHOMA: IS GRADE 3 FOR BETTER OR FOR WORSE?

EHA Library, Maria Angelopoulou, 132706

THE IMPROVING OUTCOME OF NON-HODGKIN LYMPHOMA (NHL) WITHIN 15 YEARS PERIOD – REAL WORLD DATA OF NATIONAL-WIDE LYMPHOMA PROJECT

EHA Library, Marek Trneny, 132707

THE IMPACT OF FDG PET-CT IN THE STAGING OF FOLLICULAR LYMPHOMA - A SINGLE CENTRE EXPERIENCE

EHA Library, Ruben Fernandez, 132708

RITUXIMAB MAINTENANCE IMPROVED PROGRESSION-FREE SURVIVAL AND REDUCED THE INCIDENCE OF TRANSFORMATION IN PATIENTS WITH FOLLICULAR LYMPHOMA

EHA Library, Yoshiharu Kusano, 132709

CLONE-SPECIFIC IGH PLASMIDS AS AN ALTERNATIVE STANDARD FOR ASSESSMENT OF MINIMAL RESIDUAL DISEASE BY REAL-TIME QUANTITATIVE PCR IN FOLLICULAR LYMPHOMA

EHA Library, Tobias Laubenstein, 132710

IS LIMITED STAGE FOLLICULAR LYMPHOMA (FL) A TRULY CURABLE DISEASE? A RETROSPECTIVE ANALYSIS ON 79 PATIENTS

EHA Library, Maria K Angelopoulou, 132711

SINGLE CENTER EXPERIENCE OF 90Y-IBRITUMOMAB TIUXETAN IN THE OLDER POPULATION WITH NON-HODGKIN LYMPHOMA

EHA Library, Vaibhav Agrawal, 132712

DISEASE SURVEILLANCE AND LONG-TERM OUTCOME OF PATIENTS WITH MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT) LYMPHOMA INVOLVING THE STOMACH: A RETROSPECTIVE MULTICENTRE STUDY OF 49 PATIENTS IN FIRST REMISSION

EHA Library, Søren Ramme Nielsen, 132713

PRE-DOSING WITH UNLABELLED ANTIBODY SIGNIFICANTLY INCREASES THE PHARMACOKINETIC EXPOSURE BUT PROTECTS AGAINST MYELOSUPPRESSION OF 177LU-LILOTOMAB IN NON-HODGKIN B-CELL LYMPHOMA PATIENTS

EHA Library, Arne Kolstad, 132714

FOLLICULAR LYMPHOMAS ARE CURABLE DISEASES. DATA FROM A RETROSPECTIVE STUDY ON 133 PATIENTS WITH AT LEAST 10 YEARS OF OBSERVATION.

EHA Library, Sofia Kovalchuk, 132715

IMPACT OF AZACITIDINE TREATMENT ON INFECTIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA, MYELODYSPLASTIC SYNDROMES AND MYELODYSPLASTIC/MYELOPROLIFERATIVE SYNDROMES

EHA Library, Carolina Villegas Da Ros, 132716

CLINIC RISK FACTORS OF REFRACTORY CMV REACTIVATION FOLLOWING ALLOGENEIC AHSCT: A SINGLE-CENTER STUDY IN CHINA

EHA Library, Huiying Qiu, 132717

INFECTIOUS CHARACTERISTICS AND LONG-TERM OUTCOME IN OBESE PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

EHA Library, Meng-Ju Li, 132718

ANTIBIOTICS VERSUS G-CSFS VERSUS A COMBINATION OF BOTH TO PREVENT INFECTIOUS COMPLICATIONS AND DEATHS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY: PRELIMINARY RESULTS OF A NETWORK META-ANALYSIS

EHA Library, Nicole Skoetz, 132719

METRONOMIC FIRST-LINE ANTIBIOTICS FOR FEBRILE NEUTROPENIA – IMPACT ON ECOLOGY AND MORTALITY IN PATIENTS TREATED FOR HAEMATOLOGIC MALIGNANCIES

EHA Library, Gee Chuan Wong, 132720

ORAL GENTAMICIN THERAPY FOR CARBAPENEM-RESISTENT KLEBSIELLA PNEUMONIAE INFECTIONS IN HEMATOLOGIC PATIENTS: A SINGLE CENTER EXPERIENCE

EHA Library, Federico Simonetti, 132721

CLINICAL SIGNIFICANCE OF SERUM HEME OXYGENASE 1 IN PATIENTS WITH SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

EHA Library, Dongjiao Wang, 132722

RESPIRATORY VIRAL INFECTIONS IN HEMATOLOGIC PATIENTS IN OUR ENVIRONMENT. A RETROSPECTIVE STUDY.

EHA Library, Raquel Cidre, 132723

PHASE 1 SUMMARY OF ANF-RHO, A NOVEL PEG-MODIFIED FILGRASTIM INVESTIGATIONAL PRODUCT WITH SUPERIOR PK/PD PROPERTIES THAT MAY PROVIDE IMPROVED CONTROL OF NEUTROPENIA DURING DOSE-DENSE CHEMOTHERAPY

EHA Library, Ronald Jubin, 132724

: INVASIVE PULMONARY ASPERGILLOSIS IN ALLOGENEIC BONE MARROW RECIPIENTS WITH Β- THALASSAEMIA MAJOR OR SICKLE CELL DISEASE: INCIDENCE AND RISK FACTORS.

EHA Library, Katia Paciaroni, 132725

EARLY AND RAPID INCREMENT OF CRP AND IL-8 LEVELS TOGETHER WITH FASTER AND DEEPER DECLINING OF LEUKOCYTES PREDICT FOR TYPHLITIS DEVELOPMENT IN TREATED AML PATIENTS.

EHA Library, Lambert Span, 132726

PRESEPSIN (SOLUBLE CD14 SUBTYPE) IS ELEVATED IN FEBRILE NEUTROPENIC PATIENTS WITH HEMATOLOGICAL MALIGNANCY: USEFULNESS AS ONE ANOTHER BIOMAKER

EHA Library, Norifumi Sugawara, 132727

INVASIVE ASPEGILLOSIS IN PATIENTS WITH ACUTE LEUKEMIAS: PROGNOSTIC VALUE OF LABORATORY BIOMARKERS DEFINING HIGH RISK PATIENTS

EHA Library, Ana VIDOVIC, 132728

HEPATITIS B IMMUNE STATUS IN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Yasmine El Chazli, 132729

IMPACT OF RESPIRATORY VIRUSES IN IMMUNOCOMPROMISED PEDIATRIC HEMATOLOGY PATIENTS

EHA Library, Menie Rompola, 132730

VORICONAZOLE AS PRIMARY PROPHYLAXIS OF FUNGAL INFECTIONS IN HIGH-RISK HEMATOLOGIC PATIENTS: NO NEED FOR EMPIRICAL ANTI-FUNGAL THERAPY.

EHA Library, Amaya Zabalza, 132731

RANDOMISED COMPARISON OF PALONOSETRON AND ONDANSETRON BOTH COMBINED WITH DEXAMETHASONE IN PREVENTION OF EMESIS IN LYMPHOMA PATIENTS RECEIVING MODERATELY EMETOGENIC REGIMEN BENDAMUSTINE AND RITUXIMAB

EHA Library, Vadim Ptushkin, 132732

EFFICACY AND SAFETY OF MICAFUNGIN ON THE MANAGEMENT OF INVASIVE FUNGAL INFECTIONS AMONG PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AT TERTIARY HOSPITALS IN GREECE- THE ASPIRE STUDY

EHA Library, Maria Kotsopoulou, 132733

ANTIRETROVIRAL THERAPY AND CHEMOTHERAPY IN PATIENTS WITH HIV INFECTION AND HAEMATOLOGICAL DISEASE - TOXICITY ASSESSMENT

EHA Library, Paula Cristina Gaspar Brandao de Sousa e Sant, 132734

RE-EVALUATING THE IMPACT OF INVASIVE ASPERGILLOSIS ON THE PROGNOSIS OF ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Marie-Pierre Ledoux, 132735

PRIMARY ANTIFUNGAL PROPHYLAXIS (PAP) WITH MICAFUNGIN AT THE DOSE 50MG PER DAY IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) DURING INDUCTION CHEMOTHERAPY: THE „REAL-LIFE“ EVALUATION

EHA Library, Tomas Kabut, 132736

COMPARISON OF DE-ESCALATION AND NON-DE-ESCALATION EMPIRICAL THERAPY FOR CONTROLLING INFECTION IN PATIENTS WITH SEVERE APLASTIC ANEMIA TREATED WITH ANTITHYMOCYTE GLOBULIN

EHA Library, Rong Fu, 132737

A RETROSPECTIVE ANALYSIS ABOUT STENOTROPHOMONAS MALTOPHILIA SEPSIS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCY: A SINGLE CENTER STUDY FOR 12 YEARS

EHA Library, Maki Asahi, 132738

RIGOSERTIB (RIGO) COMBINED WITH AZACITIDINE (AZA) IN VITRO & CLINICAL: MODULATES EPIGENETIC EVENTS AND OVERCOMES CLINICAL RESISTANCE TO HYPOMETHYLATING AGENTS (HMA) IN MYELODYSPLASTIC SYNDROMES (MDS)

EHA Library, Lewis Silverman, 132739

PREVALENCE AND DYNAMICS OF LEUKEMIA-ASSOCIATED MUTATIONS IN ELDERLY INDIVIDUALS WITHOUT HEMATOLOGIC DISORDERS

EHA Library, Thomas Ernst, 132740

FLOW CYTOMETRIC RESPONSE MONITORING IN MDS WITH DEL(5Q) USING A SIMPLE 5-PARAMETER-SCORE – A TWO-CENTER-EXPERIANCE

EHA Library, Uta OELSCHLAEGEL, 132741

ABT-199 EFFECTIVELY INDUCES APOPTOSIS IN HIGH-RISK MDS PROGENITOR CELLS IRRESPECTIVE OF PROGNOSTICALLY ADVERSE MUTATIONS OF TP53, EZH2, RUNX1, AND ASXL1

EHA Library, Johanna Kauschinger, 132742

DYNAMICS OF GENE EXPRESSION CHANGES IN THE DEVELOPMENT OF MYELODYSPLASTIC SYNDROMES AND EVOLUTION TO ACUTE MYELOID LEUKEMIA

EHA Library, Maria Hernandez Sanchez, 132743

BONE HOMEOSTASIS IS SIGNIFICANTLY ALTERED IN A MYELODYSPLASTIC SYNDROME MOUSE MODEL

EHA Library, Heike Weidner, 132744

GENETIC FACTORS ASSOCIATED WITH EVOLUTION OF MYELODYSPLASTIC SYNDROMES TO SECONDARY CHRONIC MYELOMONOCYTIC LEUKEMIA.

EHA Library, Ryunosuke Saiki, 132745

SCAPER AND RPRD1A: TWO NOVEL CANDIDATES IN THE PATHOGENESIS OF FAMILIAL PLATELET DISORDER WITH PROPENSITY TO DEVELOP MYELOID MALIGNANCIES (FPD/AML)

EHA Library, Majidi Majidi, 132746

REAL-TIME DEFORMABILITY CYTOMETRY (RT-DC) AS NOVEL DIAGNOSTIC TOOL IN MYELODYSPLASTIC SYNDROMES

EHA Library, Ekaterina Bulycheva, 132747

SPATIAL INTERACTION OF CYTOGENETIC AND MOLECULAR MUTATIONS IN MYELODYSPLASTIC SYNDROMES

EHA Library, Detlef Haase, 132748

MONUCLEAR MYELOID-DERIVED SUPPRESSOR CELLS (MO-MDSC) EXPANSION AND PROGRESSION IN MYELODYSPLASTIC SYNDROMES

EHA Library, Francisca Hernandez Mohedo, 132749

ABERRANT METHYLATION OF PROMOTER REGIONS OF SOX7, P15INK4B AND WNT PATHWAY ANTAGONIST GENES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Ivan Kostroma, 132750

IRON OVERLOAD-ASSOCIATED GENETIC INSTABILITY IN MYELODYSPLASTIC SYNDROME

EHA Library, Detlef Haase, 132751

CONVENTIONAL CYTOGENETICS, ACGH, AND PCR AS INTEGRATED WORKUP FOR A CORRECT DIAGNOSIS OF MDS.

EHA Library, Sara Galimberti, 132752

CLONAL DYNAMICS OF TWO DISTINCT CLONES IN LEUKEMIC TRANSFORMATION FROM MDS WITH ISOLATED DEL(5Q) HARBORING TP53 MUTATION

EHA Library, Hiroyuki Tsukamoto, 132753

THE DNA METHYLATION INHIBITORS AZACITIDINE AND DECITABINE ACTIVATE UNIQUE AND COMMON TRANSCRIPTIONAL PATHWAYS THAT INCLUDE POTENTIAL NOVEL MARKERS OF RESPONSE

EHA Library, Kathryn Clarke, 132754

INTEGRATED ANALYSIS OF BOTH BIOLOGICAL AND MOLECULAR EFFECTS OF THE EPIGENETIC MODIFYING AGENT ROMIDEPSIN IN MDS/AML

EHA Library, Kathryn Clarke, 132755

THERAPY RELATED MYELOID NEOPLASM FOLLOWING RADIOTHERAPY HAS HIGHER INCIDENCE OF POOR RISK CYTOGENETICS AND ARE ASSOCIATED WITH POOR SURVIVAL COMPARED TO DE NOVO MDS CASES

EHA Library, Deepak Singhal, 132756

POLY [ADP-RIBOSE] POLYMERASE 1 (PARP-1) EXPRESSION IS CORRELATED TO THE TYPE OF MYELODYSPLASTIC SYNDROME ACCORDING TO BOTH WHO CLASSIFICATION AND IPSS SCORE

EHA Library, Panagiotis Diamantopoulos, 132757

NEXT GENERATION SEQUENCING IN HIGH RISK MYELODYSPLASTIC SYNDROMES AND SECONDARY ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH AZACITIDINE ACCORDING TO HIGH RISK MDS 2009 PROTOCOL FROM CETLAM GROUP.

EHA Library, Marta Cabezón, 132758